Form 4: Alaunos Therapeutics Director Receives Stock Grant
Insider Transaction (Form 4)
Michael Allen Jerman, a Director of Alaunos Therapeutics, Inc., received 8,138 shares of common stock on July 23, 2026.
Summary
- Grant/award: acquired 8,138 Common Stock at $1.92 ($15,625) on July 23, 2026; holds 23,759 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Michael Allen Jerman — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-23 | Grant/award | Common Stock | 8,138 | $2 | $15.6K | 23,759 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-23 | Grant/award (8,138 shares) |
Keywords
insider transaction, Form 4, TCRT, Alaunos Therapeutics, Inc., neutral, Michael Allen Jerman
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.